Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells

Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells

Pioglitazone, a hypoglycemic agent, has been shown to increase plasma HDL cholesterol, but the mechanism is incompletely understood. We further investigated effects of pioglitazone on transcriptional regulation of apolipoprotein (apo)A-I gene and functional properties of pioglitazone-induced apoA-I-...

Full description

Bibliographic Details
Main Authors:	Lin-Hua Zhang, Vaijinath S. Kamanna, Shobha H. Ganji, Xi-Ming Xiong, Moti L. Kashyap
Format:	Article
Language:	English
Published:	Elsevier 2010-08-01
Series:	Journal of Lipid Research
Subjects:	HDL/metabolism atherosclerosis nuclear receptors cholesterol
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520370577

Similar Items

Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL
by: Lin-Hua Zhang, et al.
Published: (2008-06-01)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
by: Anna Wolska, et al.
Published: (2021-03-01)

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients*
by: LeAnne T. Bloedon, et al.
Published: (2008-06-01)

Extra Virgin Olive Oil Prevents the Age-Related Shifts of the Distribution of HDL Subclasses and Improves Their Functionality
by: Alyann Otrante, et al.
Published: (2021-06-01)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
by: Juraj Koska, et al.
Published: (2022-09-01)

Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase
by: Stein Roosbeek, et al.
Published: (2001-01-01)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01)

The prevention and treatment effects of egg yolk high density lipoprotein on the formation of atherosclerosis plaque in rabbits
by: Shima Eftekhar, et al.
Published: (2015-04-01)

Extensive diet-induced atherosclerosis in scavenger receptor class B type 1-deficient mice is associated with substantial leukocytosis and elevated vascular cell adhesion molecule-1 expression in coronary artery endothelium
by: Mark T. Fuller, et al.
Published: (2023-01-01)

Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation[S]
by: Kohjiro Nagao, et al.
Published: (2009-06-01)

β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells
by: Gao XQ, et al.
Published: (2017-03-01)

A Systematic Review of Apolipoprotein A-I Mimetic Peptides for Atherosclerosis Therapy via Activation of Reverse Cholesterol Transport Pathway
by: Aiman Asaduddin, et al.
Published: (2022-11-01)

Functional diversity of high-density lipoproteins: finding the golden mean
by: V. A. Metelskaya
Published: (2021-06-01)

Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
by: Arnold von Eckardstein, et al.
Published: (1998-05-01)

Periodontitis decreases the antiatherogenic potency of high density lipoprotein
by: Pirkko J. Pussinen, et al.
Published: (2004-01-01)

Cholesterol efflux pathways regulate myelopoiesis: A potential link to altered macrophage function in atherosclerosis
by: Andrew James Murphy, et al.
Published: (2014-10-01)

Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
by: Hong Y. Choi, et al.
Published: (2021-05-01)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023-06-01)

Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin*
by: Priscilla Jaichander, et al.
Published: (2008-10-01)

Factores de riesgo cardiovascular en estudiantes universitarios chilenos Cardiovascular risk factors in Chilean university students
by: María Teresa Chiang-Salgado, et al.
Published: (1999-12-01)

Apolipoprotein A-I: structure–function relationships
by: Philippe G. Frank, et al.
Published: (2000-06-01)

Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development
by: Marija Vavlukis, et al.
Published: (2022-09-01)

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
by: Jeffrey S. Cohn, et al.
Published: (2004-08-01)

NON-CLINICAL DEVELOPMENT OF CER-001
by: Ronald eBarbaras
Published: (2015-10-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells
by: Allan D. Sniderman, et al.
Published: (2003-03-01)

Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI
by: Patricia G. Yancey, et al.
Published: (2007-05-01)

<i>Acanthaster planci</i> Inhibits PCSK9 Gene Expression via Peroxisome Proliferator Response Element (PPRE) and Activation of MEK and PKC Signaling Pathways in Human Liver Cells
by: Nurjannatul Naim Kamaruddin, et al.
Published: (2022-02-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
by: Nicolas Vuilleumier, et al.
Published: (2013-05-01)

The Role of the Low-Density Lipoprotein/High-Density Lipoprotein Cholesterol Ratio as an Atherogenic Risk Factor in Young Adults with Ischemic Stroke: A Case—Control Study
by: Sibel Ciplak, et al.
Published: (2023-08-01)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
by: Anouar Hafiane, et al.
Published: (2022-04-01)

Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population
by: Alexandre Vallée
Published: (2022-05-01)

How good can HDL Cholesterol be? Recent Evidence and way forward for Clinical Practice
by: Sikandar Hayat Khan
Published: (2023-06-01)

Variations in high density cholesterol levels based on apolipoprotein E variant and exercise type
by: Huan-Cheng Chang, et al.
Published: (2023-06-01)

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1
by: Karen Y.Y. Fung, et al.
Published: (2024-04-01)

Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
by: Malgorzata Sidorkiewicz
Published: (2023-02-01)

Apolipoprotein A-II, a Player in Multiple Processes and Diseases
by: Gabriela Florea, et al.
Published: (2022-07-01)

VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice*[S]
by: Paul A. VanderLaan, et al.
Published: (2009-03-01)

The –514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity
by: Gloria Lena Vega, et al.
Published: (1998-07-01)